Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Congress
False Claims Amendments Act of 2021 Continues to Wind Through Congress
Earlier this year, Senator Chuck Grassley and a bipartisan group of senators introduced the False Claims Amendment Act of 2021,…
Legislation Introduced to Create an Office of Rural Health
On November 3, 2021, Congressman A. Donald McEachin and Senator Jeff Merkley introduced the bicameral Rural Health Equity Act. If…
November Issue of Policy and Medicine Compliance Update — Features…
Policy and Medicine Compliance Update is our monthly compliance publication designed to help compliance professionals go in depth…
Senate Holds Hearing to Discuss the Future of Telehealth
On October 7, the Senate Commerce Subcommittee on Communications, Media, and Broadband held a hearing to discuss the future of…
Senate Introduces Bipartisan Prior Authorization Legislation: Timely Access…
On October 20, 2021, a group of bipartisan United States Senators (Roger Marshall, MD (R-KS); Krysten Sinema (D-AZ); and John…
Biopharmaceutical Companies Send Open Letter to Congress
On September 15, 2021, member companies of the Pharmaceutical Research and Manufacturers of America (PhRMA) made public an open…
CME Coalition Endorses Several Bills in Congress Supporting CME
A handful of proposed bills have been introduced this year in both chambers of the United States Congress that touch upon…
Senate Passes Legislation on Mental Health for Health Care Professionals
On August 6, 2021, the Dr. Lorna Breen Health Care Provider Protection Act unanimously passed the United States Senate. The…
CBO Simulates the Elijah E. Cummings Lower Drug Costs Now Act
The Congressional Budget Office (CBO) recently released a Simulation Model of New Drug Development that mimicked the Elijah E.…
Alternative Drug Pricing Legislation Introduced by Moderate Democrats
Centrist Democrats in the United States House of Representatives are working on introducing an alternate approach to drug pricing…